Home
>
National Drug Code (NDC)
>
Levothyroxine Sodium
Levothyroxine Sodium - 51079-445-20 - (levothyroxine sodium)
Drug Information of Levothyroxine Sodium
| Product NDC: | 51079-445 |
| Proprietary Name: | Levothyroxine Sodium |
| Non Proprietary Name: | levothyroxine sodium |
| Active Ingredient(s): | 150 ug/1 & nbsp; levothyroxine sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Levothyroxine Sodium
| Product NDC: | 51079-445 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076187 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101029 |
Package Information of Levothyroxine Sodium
| Package NDC: | 51079-445-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-445-20) > 1 TABLET in 1 BLISTER PACK (51079-445-01) |
NDC Information of Levothyroxine Sodium
| NDC Code | 51079-445-20 |
| Proprietary Name | Levothyroxine Sodium |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-445-20) > 1 TABLET in 1 BLISTER PACK (51079-445-01) |
| Product NDC | 51079-445 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levothyroxine sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101029 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | LEVOTHYROXINE SODIUM |
| Strength Number | 150 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |
